Numeric Investors’s Epizyme, Inc EPZM Stock Holding History

Numeric Investors’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-24,900	Closed	-$376K	–	1227
2017 Q2	$376K	Buy	+24,900	New	+$376K	﹤0.01%	874
2015 Q1	–	Sell	-58,896	Closed	-$1.11M	–	1084
2014 Q4	$1.11M	Sell	58,896 -86,904	-60%	-$2.03M	0.01%	439
2014 Q3	$3.95M	Buy	+145,800	New	+$4.53M	0.06%	250
2014 Q2	–	Sell	-257,574	Closed	-$5.87M	–	940
2014 Q1	$5.87M	Buy	+257,574	New	+$7.81M	0.1%	213

Other funds holding EPZM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Numeric Investors's EPZM Position: Q3 2017 in Review

Numeric Investors sold out of Epizyme, Inc (EPZM) in Q3 2017, closing a stake of 24,900 shares — an estimated $376K sold.

Numeric Investors first reported a position in EPZM in Q1 2014 and held it in 4 quarters. The position peaked at $5.87M in Q1 2014. 104 funds tracked by Wall St. Rank hold EPZM as of Q3 2017.

Numeric Investors reported no remaining Epizyme, Inc position as of Q3 2017 after selling out during the quarter.
Numeric Investors sold 24,900 Epizyme, Inc shares in Q3 2017, an estimated $376K.
Numeric Investors first reported a position in Epizyme, Inc in Q1 2014 and held it in 4 quarters.
Numeric Investors's Epizyme, Inc position peaked at $5.87M in Q1 2014.
104 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2017.

Based on Numeric Investors's 13F filing for Q3 2017, filed 14 Nov 2017.